Suppr超能文献

新冠疫情期间印度平衡医疗保健与经济的经验

Balancing Healthcare and Economy Amidst the COVID-19 Pandemic: An Indian Experience.

作者信息

Dhar Ruby, Jee Babban, Karmakar Subhradip

机构信息

Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.

Department of Health Research, Ministry of Health and Family Welfare, Government of India, New Delhi, India.

出版信息

Risk Manag Healthc Policy. 2021 Feb 26;14:827-833. doi: 10.2147/RMHP.S291084. eCollection 2021.

Abstract

With its 1.3 billion population and faced with the COVID-19 pandemic, India is at the junction of two crucial decisions, balancing healthcare and the economy. To prevent the community spread of the virus, the Indian Government imposed a nationwide lockdown. Though initially successful to some extent in containing the disease spread, the extended lockdown eventually leads to a spiraling out effect resulting in the slowdown of the economy, which, in turn, lead to widespread consequences affecting the lives of millions of people, mostly those at the base of the social pyramid. We investigated the implications of few government policies taken during this pandemic and their impact on society, thereby suggesting short-term crisis management with long-term solutions. Here, we present a comprehensive account of Indian policy in dealing with the COVID-19 crisis, balancing both economic and public health. We also explored a future contingency plan for risk mitigation along with few recommendations. This viewpoint will be useful for effective healthcare management and the economy in Asia's populous nation in the COVID-19 and prepare for a future crisis of this nature.

摘要

印度拥有13亿人口,且面临新冠疫情,正处于两个关键决策的交汇点,即在医疗保健和经济之间寻求平衡。为防止病毒在社区传播,印度政府实施了全国范围的封锁。尽管最初在一定程度上成功遏制了疾病传播,但延长的封锁最终导致了一种螺旋式的负面影响,致使经济放缓,进而产生了广泛的后果,影响了数百万人的生活,其中大多数是社会金字塔底层的人群。我们研究了疫情期间政府采取的一些政策的影响及其对社会的冲击,从而提出了兼具短期危机管理和长期解决方案的建议。在此,我们全面阐述了印度应对新冠疫情危机的政策,兼顾了经济和公共卫生两方面。我们还探索了未来的风险缓解应急计划并给出了一些建议。这一观点对于这个亚洲人口大国在新冠疫情期间进行有效的医疗管理和经济调控,并为未来此类性质的危机做好准备将有所助益。

相似文献

1
Balancing Healthcare and Economy Amidst the COVID-19 Pandemic: An Indian Experience.
Risk Manag Healthc Policy. 2021 Feb 26;14:827-833. doi: 10.2147/RMHP.S291084. eCollection 2021.
3
Effects of the COVID-19 pandemic in India: An analysis of policy and technological interventions.
Health Policy Technol. 2021 Mar;10(1):151-164. doi: 10.1016/j.hlpt.2020.12.001. Epub 2020 Dec 25.
4
Can India stay immune enough to combat COVID-19 pandemic? An economic query.
J Public Aff. 2020 Nov;20(4):e2157. doi: 10.1002/pa.2157. Epub 2020 Jun 19.
7
COVID-19 pandemic in China: Context, experience and lessons.
Health Policy Technol. 2020 Dec;9(4):639-648. doi: 10.1016/j.hlpt.2020.08.006. Epub 2020 Aug 27.
8
Psychosocial and Socio-Economic Crisis in Bangladesh Due to COVID-19 Pandemic: A Perception-Based Assessment.
Front Public Health. 2020 Jun 26;8:341. doi: 10.3389/fpubh.2020.00341. eCollection 2020.
9
COVID-19: The need for an Australian economic pandemic response plan.
Health Policy Technol. 2020 Dec;9(4):488-502. doi: 10.1016/j.hlpt.2020.08.017. Epub 2020 Aug 28.
10
COVID-19 Lessons and Post-pandemic Recovery: A Case of Latvia.
Front Public Health. 2022 Apr 7;10:866639. doi: 10.3389/fpubh.2022.866639. eCollection 2022.

引用本文的文献

1
COVID-19 vaccination acceptance and adherence among pregnant and lactating high-risk group individuals of Maharashtra State, India.
J Educ Health Promot. 2023 Jan 31;12:36. doi: 10.4103/jehp.jehp_204_22. eCollection 2023.
2
Behind the Frontline: A Review on the Impact of COVID-19 Pandemic on Healthcare Workers.
Cureus. 2022 Sep 20;14(9):e29349. doi: 10.7759/cureus.29349. eCollection 2022 Sep.
3
Coronavirus pandemic in the Nordic countries: Health policy and economy trade-off.
J Glob Health. 2022 Aug 8;12:05017. doi: 10.7189/jogh.12.05017.
4
Burden of COVID-19 and case fatality rate in Pune, India: an analysis of the first and second wave of the pandemic.
IJID Reg. 2022 Mar;2:74-81. doi: 10.1016/j.ijregi.2021.12.006. Epub 2021 Dec 18.

本文引用的文献

1
2
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med. 2021 Mar 4;384(9):795-807. doi: 10.1056/NEJMoa2031994. Epub 2020 Dec 11.
3
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
4
Private Health Sector in India-Ready and Willing, Yet Underutilized in the Covid-19 Pandemic: A Cross-Sectional Study.
Front Public Health. 2020 Oct 16;8:571419. doi: 10.3389/fpubh.2020.571419. eCollection 2020.
5
Vaccines for COVID-19.
Clin Exp Immunol. 2020 Nov;202(2):162-192. doi: 10.1111/cei.13517. Epub 2020 Oct 18.
6
A living WHO guideline on drugs for covid-19.
BMJ. 2020 Sep 4;370:m3379. doi: 10.1136/bmj.m3379.
7
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
J Gen Intern Med. 2020 Nov;35(11):3308-3314. doi: 10.1007/s11606-020-06146-w. Epub 2020 Sep 3.
8
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.
Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16.
9
The Covid-19 Vaccine-Development Multiverse.
N Engl J Med. 2020 Nov 12;383(20):1986-1988. doi: 10.1056/NEJMe2025111. Epub 2020 Jul 14.
10
Vaccines for COVID-19: The current state of play.
Paediatr Respir Rev. 2020 Sep;35:43-49. doi: 10.1016/j.prrv.2020.06.010. Epub 2020 Jun 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验